NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approximately 66% Reduction in Net Loss
Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pharmacy Footprint HALLANDALE BEACH, Fla., Nov. 12, 2026 — NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services…














